Breaking News

Trump Admin Taps Virginia Company to Make COVID-19 Medicines

Phlow gets $354mn govt. deal to supply essential drugs; plans to build API reserve in US to reduce America’s dependency on foreign nations for drug supply

By: Contract Pharma

Contract Pharma Staff

Phlow, a U.S.-based, public benefit drug manufacturing corporation, has received federal government funding of $354 million for advanced manufacturing of America’s most essential medicines at risk of shortage, including medicines for the COVID-19 pandemic response.   This project has been funded with federal funds from the Biomedical Advanced Research and Development Authority (BARDA), part of the office of Assistant Secretary for Preparedness and Response (ASPR) at the U.S. Department of ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters